Hybrid closed-loop therapy: the calm before the storm
DOI:
https://doi.org/10.15277/bjd.2023.426Keywords:
closed-loop, technology, accessReferences
Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 2018;392(10155):1321-9. https://doi.org/10.S0140-6736(18)31947-0
Brown SA, Kovatchev BP, Raghinanaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 2019;381(18):1707-17. https://doi.org/10.1056/NEJMoa1907863
Brown SA, Forlenza GP, Bode BW, et al. Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 2021;44(7):1630-40. https://doi.org/10.2337/dc21-0172
Choudhary P, Kolassa R, Keuthaage W, et al. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study. Lancet Diabetes Endocrinol 2022;10(10):720-31. https://doi.org/10.1016/S2213-8587(22)00212-1
Crabtree TSJ, Griffin TP, Yap YW, et al. Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study. Diabetes Care 2023;46(10):1831-8. https://doi.org/10.2337/dc23-0635
Cobry EC, Kanapka LG, Cengiz E, et al. Health-related quality of life and treatment satisfaction in parents and children with type 1 diabetes using closed-loop control. Diabetes Technol Ther 2021; 23(6):401-09. https://doi.org/10.1089/dia.2020.0532
Lee TTM, Collett C, Bergford S, et al. Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med 2023;389(17): 1566-78. https://doi.org/10.1056/NEJMoa2303911
Diabetes Technology Network UK. Guidelines for managing continuous subcutaneous insulin infusion (CSII, or ‘insulin pump’) therapy in hospitalised patients. 2019 [cited 2023 26/10/2023]; Available from: https://abcd.care/sites/abcd.care/files/CSII_DTN_FINAL%20210218.pdf.
National Institute for Health and Care Excellence. Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes [Draft] - TA10845. 2023 [cited 2023 26/10/2023]; Available from: https://www.nice.org.uk/guidance/indevelopment/gid-ta10845/documents.
Griffin TP, Gallen G, Hartnell S, et al. UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for Hybrid Closed-Loop Therapy. Diabetic Medicine 2023;40(7):e15078. https://doi.org/10.1111/dme.15078
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
